The role of microRNAs in hematopoietic stem cell and leukemic stem cell function

Stephen S. Chung, Wenhuo Ho, Christopher Y. Park

Research output: Contribution to journalReview article

18 Citations (Scopus)

Abstract

Hematopoietic stem cells (HSCs) are defined by their ability to self-renew and reconstitute all elements of the hematopoietic system. Acute myeloid leukemia (AML) is thought to arise from, and be maintained by, leukemic stem cells (LSCs), which exhibit similar features to HSCs, including the abilities to self-renew and differentiate into non-self-renewing cells. Acquisition of stem-cell-like characteristics by the LSCs is likely mediated in part by molecular mechanisms that normally regulate HSC function. Thus, understanding the shared and unique aspects of the molecular regulation of these cell populations will be important to understanding the relationship between normal hematopoiesis and leukemogenesis. MicroRNAs (miRNAs) are small noncoding RNAs that act at the posttranscriptional level to regulate protein expression. Unfortunately, most investigations of the role of miRNAs in normal hematopoiesis have been restricted to studies of their effects on lineage commitment in progenitors and mature effector cell function, but not on HSCs. Recent studies have identified miRNAs that enhance HSC function, and an abundance of profiling studies using primary AML samples have identified dysregulated miRNAs that may target genes implicated in self-renewal (HOX genes, P53, and PTEN), thus providing a potential link between normal and malignant stem cells. While these studies as well as recent in vivo models of miRNA-induced leukemogenesis (e.g. miR-29a, miR-125b) suggest a role for miRNAs in the development of AML, future studies using serial transplantation of primary AML blasts, from both mouse models and primary human AML specimens, will be necessary to assess the roles of miRNAs in LSC biology.

Original languageEnglish (US)
Pages (from-to)317-334
Number of pages18
JournalTherapeutic Advances in Hematology
Volume2
Issue number5
DOIs
StatePublished - Oct 2011
Externally publishedYes

Fingerprint

Hematopoietic Stem Cells
MicroRNAs
Stem Cells
Acute Myeloid Leukemia
Hematopoiesis
Hematopoietic System
Small Untranslated RNA
p53 Genes
Cell Biology
Transplantation
Population
Genes
Proteins

Keywords

  • acute myeloid leukemia
  • experimental models of leukemia
  • hematopoiesis
  • hematopoietic stem cells
  • leukemia stem cell
  • microRNAs

ASJC Scopus subject areas

  • Hematology

Cite this

The role of microRNAs in hematopoietic stem cell and leukemic stem cell function. / Chung, Stephen S.; Ho, Wenhuo; Park, Christopher Y.

In: Therapeutic Advances in Hematology, Vol. 2, No. 5, 10.2011, p. 317-334.

Research output: Contribution to journalReview article

@article{b7cde51f23314effa6ce6094618ce6a1,
title = "The role of microRNAs in hematopoietic stem cell and leukemic stem cell function",
abstract = "Hematopoietic stem cells (HSCs) are defined by their ability to self-renew and reconstitute all elements of the hematopoietic system. Acute myeloid leukemia (AML) is thought to arise from, and be maintained by, leukemic stem cells (LSCs), which exhibit similar features to HSCs, including the abilities to self-renew and differentiate into non-self-renewing cells. Acquisition of stem-cell-like characteristics by the LSCs is likely mediated in part by molecular mechanisms that normally regulate HSC function. Thus, understanding the shared and unique aspects of the molecular regulation of these cell populations will be important to understanding the relationship between normal hematopoiesis and leukemogenesis. MicroRNAs (miRNAs) are small noncoding RNAs that act at the posttranscriptional level to regulate protein expression. Unfortunately, most investigations of the role of miRNAs in normal hematopoiesis have been restricted to studies of their effects on lineage commitment in progenitors and mature effector cell function, but not on HSCs. Recent studies have identified miRNAs that enhance HSC function, and an abundance of profiling studies using primary AML samples have identified dysregulated miRNAs that may target genes implicated in self-renewal (HOX genes, P53, and PTEN), thus providing a potential link between normal and malignant stem cells. While these studies as well as recent in vivo models of miRNA-induced leukemogenesis (e.g. miR-29a, miR-125b) suggest a role for miRNAs in the development of AML, future studies using serial transplantation of primary AML blasts, from both mouse models and primary human AML specimens, will be necessary to assess the roles of miRNAs in LSC biology.",
keywords = "acute myeloid leukemia, experimental models of leukemia, hematopoiesis, hematopoietic stem cells, leukemia stem cell, microRNAs",
author = "Chung, {Stephen S.} and Wenhuo Ho and Park, {Christopher Y.}",
year = "2011",
month = "10",
doi = "10.1177/2040620711410772",
language = "English (US)",
volume = "2",
pages = "317--334",
journal = "Therapeutic Advances in Hematology",
issn = "2040-6207",
number = "5",

}

TY - JOUR

T1 - The role of microRNAs in hematopoietic stem cell and leukemic stem cell function

AU - Chung, Stephen S.

AU - Ho, Wenhuo

AU - Park, Christopher Y.

PY - 2011/10

Y1 - 2011/10

N2 - Hematopoietic stem cells (HSCs) are defined by their ability to self-renew and reconstitute all elements of the hematopoietic system. Acute myeloid leukemia (AML) is thought to arise from, and be maintained by, leukemic stem cells (LSCs), which exhibit similar features to HSCs, including the abilities to self-renew and differentiate into non-self-renewing cells. Acquisition of stem-cell-like characteristics by the LSCs is likely mediated in part by molecular mechanisms that normally regulate HSC function. Thus, understanding the shared and unique aspects of the molecular regulation of these cell populations will be important to understanding the relationship between normal hematopoiesis and leukemogenesis. MicroRNAs (miRNAs) are small noncoding RNAs that act at the posttranscriptional level to regulate protein expression. Unfortunately, most investigations of the role of miRNAs in normal hematopoiesis have been restricted to studies of their effects on lineage commitment in progenitors and mature effector cell function, but not on HSCs. Recent studies have identified miRNAs that enhance HSC function, and an abundance of profiling studies using primary AML samples have identified dysregulated miRNAs that may target genes implicated in self-renewal (HOX genes, P53, and PTEN), thus providing a potential link between normal and malignant stem cells. While these studies as well as recent in vivo models of miRNA-induced leukemogenesis (e.g. miR-29a, miR-125b) suggest a role for miRNAs in the development of AML, future studies using serial transplantation of primary AML blasts, from both mouse models and primary human AML specimens, will be necessary to assess the roles of miRNAs in LSC biology.

AB - Hematopoietic stem cells (HSCs) are defined by their ability to self-renew and reconstitute all elements of the hematopoietic system. Acute myeloid leukemia (AML) is thought to arise from, and be maintained by, leukemic stem cells (LSCs), which exhibit similar features to HSCs, including the abilities to self-renew and differentiate into non-self-renewing cells. Acquisition of stem-cell-like characteristics by the LSCs is likely mediated in part by molecular mechanisms that normally regulate HSC function. Thus, understanding the shared and unique aspects of the molecular regulation of these cell populations will be important to understanding the relationship between normal hematopoiesis and leukemogenesis. MicroRNAs (miRNAs) are small noncoding RNAs that act at the posttranscriptional level to regulate protein expression. Unfortunately, most investigations of the role of miRNAs in normal hematopoiesis have been restricted to studies of their effects on lineage commitment in progenitors and mature effector cell function, but not on HSCs. Recent studies have identified miRNAs that enhance HSC function, and an abundance of profiling studies using primary AML samples have identified dysregulated miRNAs that may target genes implicated in self-renewal (HOX genes, P53, and PTEN), thus providing a potential link between normal and malignant stem cells. While these studies as well as recent in vivo models of miRNA-induced leukemogenesis (e.g. miR-29a, miR-125b) suggest a role for miRNAs in the development of AML, future studies using serial transplantation of primary AML blasts, from both mouse models and primary human AML specimens, will be necessary to assess the roles of miRNAs in LSC biology.

KW - acute myeloid leukemia

KW - experimental models of leukemia

KW - hematopoiesis

KW - hematopoietic stem cells

KW - leukemia stem cell

KW - microRNAs

UR - http://www.scopus.com/inward/record.url?scp=84993737868&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84993737868&partnerID=8YFLogxK

U2 - 10.1177/2040620711410772

DO - 10.1177/2040620711410772

M3 - Review article

C2 - 23556099

AN - SCOPUS:84993737868

VL - 2

SP - 317

EP - 334

JO - Therapeutic Advances in Hematology

JF - Therapeutic Advances in Hematology

SN - 2040-6207

IS - 5

ER -